Literature DB >> 2066239

Measures of the effects of vaccination in a randomly mixing population.

M Haber1, I M Longini, M E Halloran.   

Abstract

Vaccine efficacy in the field is often derived from the relative attack rates in the vaccinated and unvaccinated after an outbreak. In this paper, vaccine efficacy is defined in terms of the probability that the infectious agent is transmitted from an infected to a susceptible person, and a method for estimating it from the usual attack rate data is given. We explore two mechanisms of vaccine action defined by Smith et al, but include an underlying dynamic epidemic model of an acute directly transmitted disease. We show analytically that under the model in which the vaccine mechanism reduces the probability of infection given a certain exposure, vaccine efficacy based on the relative attack rates underestimates the protective effect of the vaccine based on the relative transmission probabilities. Under the other model in which the vaccine mechanism offers complete protection to a certain proportion of those vaccinated, and no protection to the other vaccinated proportion, the vaccine efficacy based on the relative attack rates will equal that based on the transmission probabilities. Parameters for the effectiveness of a vaccination programme are defined in terms of the direct and indirect benefit to a single person as well as the total and average benefit to the entire population, and derived from the dynamic model for an outbreak of an acute directly transmitted disease. These effects can also be estimated without an actual separate unvaccinated population, independent of assumptions about the vaccine mechanism. The variation of these measures as functions of the fraction of vaccinated people in the population is explored numerically.

Entities:  

Mesh:

Year:  1991        PMID: 2066239     DOI: 10.1093/ije/20.1.300

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  17 in total

1.  A method for estimating time dependent intervention benefits under arbitrarily varying age and exogenous components of hazard.

Authors:  R C Brunet; C J Struchiner; A Loinaz
Journal:  Lifetime Data Anal       Date:  2001-12       Impact factor: 1.588

2.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

3.  A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies.

Authors:  M Haber; Q An; I M Foppa; D K Shay; J M Ferdinands; W A Orenstein
Journal:  Epidemiol Infect       Date:  2014-08-22       Impact factor: 2.451

4.  A compelling demonstration of why traditional statistical regression models cannot be used to identify risk factors from case data on infectious diseases: a simulation study.

Authors:  Solveig Engebretsen; Gunnar Rø; Birgitte Freiesleben de Blasio
Journal:  BMC Med Res Methodol       Date:  2022-05-20       Impact factor: 4.612

5.  Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community.

Authors:  Kylie E C Ainslie; Michael J Haber; Ryan E Malosh; Joshua G Petrie; Arnold S Monto
Journal:  Stat Med       Date:  2017-11-28       Impact factor: 2.373

6.  Distinguishing vaccine efficacy and effectiveness.

Authors:  Eunha Shim; Alison P Galvani
Journal:  Vaccine       Date:  2012-08-31       Impact factor: 3.641

7.  Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.

Authors:  Tatiana M Lanzieri; Stephanie R Bialek; Ismael R Ortega-Sanchez; Manoj Gambhir
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

8.  Impact and effectiveness of a conjugate vaccine against invasive pneumococcal disease in Finland - a modelling approach.

Authors:  Hanna Rinta-Kokko; Markku Nurhonen; Kari Auranen
Journal:  Hum Vaccin Immunother       Date:  2020-12-17       Impact factor: 3.452

9.  Real-time investigation of measles epidemics with estimate of vaccine efficacy.

Authors:  Keisuke Ejima; Ryosuke Omori; Kazuyuki Aihara; Hiroshi Nishiura
Journal:  Int J Biol Sci       Date:  2012-04-23       Impact factor: 6.580

10.  How is vaccine effectiveness scaled by the transmission dynamics of interacting pathogen strains with cross-protective immunity?

Authors:  Ryosuke Omori; Benjamin J Cowling; Hiroshi Nishiura
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.